// App-Quantinova.ai

TCT-616 : Comparison of Long-Term Outcomes with Everolimus-Eluting- and Sirolimus-Eluting Stents in Small Coronary Artery Disease

Researchers

Presenter

  • Hironori Kitabata

Principal Investigators

  • Joshua Loh

  • Gabriel Sardi

  • Ron Waksman

  • Salem Badr

  • Danny Dvir

  • Israel Barbash

  • Rebecca Torguson

  • Kenneth Kent

  • Lowell Satler

  • William Suddath

  • Augusto Pichard

Medical Centers

  • Medstar Washington Hosp Ctr, Washington, DC

  • Washington Hospital Ctr., Washington, DC

  • Georgetown University, Washington, DC

  • Medstar Washington Hosp Ctr, Washington, DC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Coronary artery lesions

  • Myocardial infarction

  • Diabetes

  • Hypertension

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved